Teleflex Incorporated (NYSE:TFX) Given Consensus Recommendation of “Moderate Buy” by Analysts

Shares of Teleflex Incorporated (NYSE:TFX) have been given a consensus rating of “Moderate Buy” by the seven ratings firms that are covering the firm, Marketbeat.com reports. Three investment analysts have rated the stock with a hold recommendation and four have issued a buy recommendation on the company. The average 12 month price objective among brokerages that have issued ratings on the stock in the last year is $252.50.

Several equities analysts recently commented on the stock. Mizuho dropped their price target on shares of Teleflex from $275.00 to $250.00 and set a “neutral” rating for the company in a research report on Friday, November 1st. Truist Financial dropped their price objective on Teleflex from $227.00 to $200.00 and set a “hold” rating for the company in a report on Wednesday, December 18th. Royal Bank of Canada lowered their price target on Teleflex from $275.00 to $245.00 and set an “outperform” rating for the company in a research report on Friday, November 1st. Needham & Company LLC restated a “hold” rating on shares of Teleflex in a report on Monday, December 16th. Finally, StockNews.com upgraded Teleflex from a “hold” rating to a “buy” rating in a report on Thursday, November 28th.

Institutional Investors Weigh In On Teleflex

Institutional investors and hedge funds have recently modified their holdings of the stock. Cromwell Holdings LLC raised its holdings in Teleflex by 59.0% during the 3rd quarter. Cromwell Holdings LLC now owns 132 shares of the medical technology company’s stock worth $33,000 after buying an additional 49 shares during the period. Avior Wealth Management LLC lifted its position in shares of Teleflex by 190.6% in the 3rd quarter. Avior Wealth Management LLC now owns 154 shares of the medical technology company’s stock valued at $38,000 after acquiring an additional 101 shares in the last quarter. Ashton Thomas Securities LLC purchased a new stake in shares of Teleflex in the 3rd quarter valued at approximately $40,000. True Wealth Design LLC boosted its stake in Teleflex by 16,600.0% in the 3rd quarter. True Wealth Design LLC now owns 167 shares of the medical technology company’s stock worth $41,000 after purchasing an additional 166 shares during the period. Finally, Canada Pension Plan Investment Board purchased a new position in Teleflex during the 2nd quarter worth approximately $42,000. Institutional investors and hedge funds own 95.62% of the company’s stock.

Teleflex Trading Down 0.6 %

Shares of TFX stock opened at $177.26 on Wednesday. The company has a market capitalization of $8.23 billion, a price-to-earnings ratio of 35.24, a PEG ratio of 1.84 and a beta of 1.16. The company has a current ratio of 2.42, a quick ratio of 1.39 and a debt-to-equity ratio of 0.37. The firm has a 50-day moving average price of $201.26 and a 200 day moving average price of $219.19. Teleflex has a twelve month low of $171.69 and a twelve month high of $256.85.

Teleflex (NYSE:TFX) last posted its quarterly earnings data on Thursday, October 31st. The medical technology company reported $3.49 earnings per share for the quarter, beating analysts’ consensus estimates of $3.38 by $0.11. Teleflex had a net margin of 7.85% and a return on equity of 14.19%. The business had revenue of $764.40 million during the quarter, compared to analyst estimates of $768.68 million. During the same quarter in the previous year, the business posted $3.64 earnings per share. The company’s revenue was up 2.4% on a year-over-year basis. Research analysts forecast that Teleflex will post 13.98 earnings per share for the current fiscal year.

Teleflex Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Monday, December 16th. Investors of record on Friday, November 15th were issued a dividend of $0.34 per share. This represents a $1.36 dividend on an annualized basis and a yield of 0.77%. The ex-dividend date was Friday, November 15th. Teleflex’s payout ratio is currently 27.04%.

About Teleflex

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.